A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections be available to older adults in the U.S. but stopped short of saying all of them should get the shots.
to prevent severe respiratory syncytial virus infections be available to older adults in the U.S. but stopped short of saying all of them should get the shots.
"Those who are at high risk for disease and for high risk for hospitalizations and death were actually not included in the trials," said committee member Dr. Helen Keipp Talbot. "The patient population that participated in the study were younger and healthier and had fewer comorbid conditions, were not immunocompromised and were not living in nursing homes."
During the meeting, the companies presented data on whether one inoculation could remain effective over the course of two RSV seasons compared with protection seen with an annual shot.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and olderThe CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
Read more »
Pfizer RSV vaccine for older adults is only slightly less effective after 18 monthsPfizer will present the RSV vaccine results to a CDC advisory committee, which will decide when and how often the shot should be administered in the U.S.
Read more »
Next Vaccine You Should Get? Health Advisers May Recommend RSV ShotsGSK and Pfizer RSV vaccines were approved earlier this year by the FDA for adults aged 60 and older.
Read more »
CDC to investigate swine flu virus behind woman's death in BrazilThe CDC plans to probe samples collected from a fatal influenza infection in Brazil, after investigators discovered the death was caused by an H1N1 variant spreading in pigs.
Read more »
Outgoing CDC director says resignation spurred by sense of accomplishment and exhaustionThe outgoing head of the Centers for Disease Control and Prevention said her reasons for stepping down were complicated, driven in part by a desire to take a break from the frenetic pace of the job during a pandemic
Read more »
Outgoing CDC director says resignation spurred by sense of accomplishment and exhaustionThe outgoing head of the Centers for Disease Control and Prevention said her reasons for stepping down were complicated, driven in part by a desire to take a break from the frenetic pace of the job during a pandemic. Dr. Rochelle Walensky surprised many in public health circles last month by announcing her departure after just two years and five months. In an interview with the Associated Press, Walensky said she decided to step down because she felt she had shepherded the agency through the pandemic and needed a break from the intense schedule she’s kept the last few years.
Read more »